These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 26934567)

  • 21. Research Progress on the Involvement of ANGPTL4 and Loss-of-Function Variants in Lipid Metabolism and Coronary Heart Disease: Is the "Prime Time" of ANGPTL4-Targeted Therapy for Coronary Heart Disease Approaching?
    Yang J; Li X; Xu D
    Cardiovasc Drugs Ther; 2021 Jun; 35(3):467-477. PubMed ID: 32500296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ANGPTL4 E40K and T266M: effects on plasma triglyceride and HDL levels, postprandial responses, and CHD risk.
    Talmud PJ; Smart M; Presswood E; Cooper JA; Nicaud V; Drenos F; Palmen J; Marmot MG; Boekholdt SM; Wareham NJ; Khaw KT; Kumari M; Humphries SE; ;
    Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2319-25. PubMed ID: 18974381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic profiling of angiopoietin-like protein 3 and 4 inhibition: a drug-target Mendelian randomization analysis.
    Wang Q; Oliver-Williams C; Raitakari OT; Viikari J; Lehtimäki T; Kähönen M; Järvelin MR; Salomaa V; Perola M; Danesh J; Kettunen J; Butterworth AS; Holmes MV; Ala-Korpela M
    Eur Heart J; 2021 Mar; 42(12):1160-1169. PubMed ID: 33351885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of angiopoietin-like protein 3 and 4 reveals structural and mechanistic similarities.
    Gunn KH; Gutgsell AR; Xu Y; Johnson CV; Liu J; Neher SB
    J Biol Chem; 2021; 296():100312. PubMed ID: 33482195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variation in ANGPTL4 and risk of coronary heart disease: the Atherosclerosis Risk in Communities Study.
    Folsom AR; Peacock JM; Demerath E; Boerwinkle E
    Metabolism; 2008 Nov; 57(11):1591-6. PubMed ID: 18940399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of triglyceride metabolism by Angiopoietin-like proteins.
    Mattijssen F; Kersten S
    Biochim Biophys Acta; 2012 May; 1821(5):782-9. PubMed ID: 22063269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ANGPTL3 Deficiency and Protection Against Coronary Artery Disease.
    Stitziel NO; Khera AV; Wang X; Bierhals AJ; Vourakis AC; Sperry AE; Natarajan P; Klarin D; Emdin CA; Zekavat SM; Nomura A; Erdmann J; Schunkert H; Samani NJ; Kraus WE; Shah SH; Yu B; Boerwinkle E; Rader DJ; Gupta N; Frossard PM; Rasheed A; Danesh J; Lander ES; Gabriel S; Saleheen D; Musunuru K; Kathiresan S;
    J Am Coll Cardiol; 2017 Apr; 69(16):2054-2063. PubMed ID: 28385496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease.
    Ference BA; Kastelein JJP; Ray KK; Ginsberg HN; Chapman MJ; Packard CJ; Laufs U; Oliver-Williams C; Wood AM; Butterworth AS; Di Angelantonio E; Danesh J; Nicholls SJ; Bhatt DL; Sabatine MS; Catapano AL
    JAMA; 2019 Jan; 321(4):364-373. PubMed ID: 30694319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The common mutations in the lipoprotein lipase gene in Italy: effects on plasma lipids and angiographically assessed coronary atherosclerosis.
    Arca M; Campagna F; Montali A; Barillà F; Mangieri E; Tanzilli G; Seccareccia F; Campa PP; Ricci G; Pannitteri G
    Clin Genet; 2000 Nov; 58(5):369-74. PubMed ID: 11140837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiopoietin-like protein 4(E40K) and ANGPTL4/8 complex have reduced, temperature-dependent LPL-inhibitory activity compared to ANGPTL4.
    Chen YQ; Pottanat TG; Siegel RW; Ehsani M; Qian YW; Roell WC; Konrad RJ
    Biochem Biophys Res Commun; 2021 Jan; 534():498-503. PubMed ID: 33239171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of angiopoietin-like 4 and lipoprotein lipase in human adipose tissue.
    Dijk W; Schutte S; Aarts EO; Janssen IMC; Afman L; Kersten S
    J Clin Lipidol; 2018; 12(3):773-783. PubMed ID: 29555209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The angiopoietin-like proteins ANGPTL3 and ANGPTL4 inhibit lipoprotein lipase activity through distinct mechanisms.
    Shan L; Yu XC; Liu Z; Hu Y; Sturgis LT; Miranda ML; Liu Q
    J Biol Chem; 2009 Jan; 284(3):1419-24. PubMed ID: 19028676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular and functional characterization of familial chylomicronemia syndrome.
    Teramoto R; Tada H; Kawashiri MA; Nohara A; Nakahashi T; Konno T; Inazu A; Mabuchi H; Yamagishi M; Hayashi K
    Atherosclerosis; 2018 Feb; 269():272-278. PubMed ID: 29153744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The S447X variant of lipoprotein lipase gene is inversely associated with severity of coronary artery disease.
    Agirbasli M; Sumerkan MC; Eren F; Agirbasli D
    Heart Vessels; 2011 Jul; 26(4):457-63. PubMed ID: 21127884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiopoietin-like protein 4 inhibition of lipoprotein lipase: evidence for reversible complex formation.
    Lafferty MJ; Bradford KC; Erie DA; Neher SB
    J Biol Chem; 2013 Oct; 288(40):28524-34. PubMed ID: 23960078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiopoietin-like protein 4 significantly predicts future cardiovascular events in coronary patients.
    Muendlein A; Saely CH; Leiherer A; Fraunberger P; Kinz E; Rein P; Vonbank A; Zanolin D; Malin C; Drexel H
    Atherosclerosis; 2014 Dec; 237(2):632-8. PubMed ID: 25463098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of lipoprotein lipase by Angptl4.
    Dijk W; Kersten S
    Trends Endocrinol Metab; 2014 Mar; 25(3):146-55. PubMed ID: 24397894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoprotein lipase gene polymorphisms in Croatian patients with coronary artery disease.
    Ferencak G; Pasalić D; Grsković B; Cheng S; Fijal B; Sesto M; Skodlar J; Rukavina AS
    Clin Chem Lab Med; 2003 Apr; 41(4):541-6. PubMed ID: 12747600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potentially protective effects of the Ser447-Ter mutation of the lipoprotein lipase gene against the development of coronary artery disease in Japanese subjects via a beneficial lipid profile.
    Sawano M; Watanabe Y; Ohmura H; Shimada K; Daida H; Mokuno H; Yamaguchi H
    Jpn Circ J; 2001 Apr; 65(4):310-4. PubMed ID: 11316129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein lipase gene variants and risk of coronary disease: a quantitative analysis of population-based studies.
    Hokanson JE
    Int J Clin Lab Res; 1997; 27(1):24-34. PubMed ID: 9144024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.